These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16001533)

  • 21. [Real and assumed potential savings in antihypertensive treatment. Right out of the magician's hat].
    Anlauf M; Hense HW
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1557-9. PubMed ID: 12854069
    [No Abstract]   [Full Text] [Related]  

  • 22. [Metoprolol CR/XL: advanced formulation of a classical beta-blocker].
    Kobalava ZhD; Gudkov KM
    Kardiologiia; 2003; 43(9):91-100. PubMed ID: 14593374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Home nursing of demented patients as an economic factor in public health].
    Hallauer J
    Krankenpfl J; 2004; 42(3-4):109-10. PubMed ID: 15311906
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmaco-economics of heart failure. The proper diuretic helps reduce costs].
    MMW Fortschr Med; 2000 Nov; 142(48):67-8. PubMed ID: 11144942
    [No Abstract]   [Full Text] [Related]  

  • 25. [Heart failure therapy. Cheap can become expensive].
    MMW Fortschr Med; 2003 Oct; 145(41):52. PubMed ID: 14655491
    [No Abstract]   [Full Text] [Related]  

  • 26. Immediate- vs extended-release metoprolol in heart failure.
    Huneycutt B
    J Fam Pract; 2003 Aug; 52(8):635-6; author reply 636. PubMed ID: 12899820
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of metoprolol on beta1 adrenergic receptor polymorphism and receptor density in urban Chinese patients with heart failure.
    Luo M; Bi Y; Xu YX
    Chin Med J (Engl); 2007 Oct; 120(19):1720-3. PubMed ID: 17935678
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparing the economy of outpatient versus inpatient rehabilitation].
    Klingelhöfer HE; Lätzsch A
    Gesundheitswesen; 2003 Mar; 65(3):163-6. PubMed ID: 12698385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budget cut for budget deficit versus beta-blocker for chronic heart failure.
    Lee YC
    Md Med J; 1996 Feb; 45(2):98. PubMed ID: 8834964
    [No Abstract]   [Full Text] [Related]  

  • 30. Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study.
    Ahrens W; Hagemeier C; Mühlbauer B; Pigeot I; Püntmann I; Reineke A; Steinbach M; Timm J
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1298-307. PubMed ID: 17957709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health and cost benefits associated with the use of metoprolol in heart attack patients.
    Fernández-Jiménez R; Ibanez B
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):687-9. PubMed ID: 25231274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [When is admission of geriatric patients to the intensive care unit justified?].
    Panknin HT; Füsgen I
    Krankenpfl J; 2000 Jun; 38(5):166-8. PubMed ID: 11992949
    [No Abstract]   [Full Text] [Related]  

  • 33. [Not just in the East: progressively shorter lengths of stay for patients. Clinics save, family physicians sigh].
    Thomas A
    MMW Fortschr Med; 2006 Jan; 148(1-2):44-5. PubMed ID: 16610416
    [No Abstract]   [Full Text] [Related]  

  • 34. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Wikstrand J; Fagerberg B; Goldstein S; Kjekshus J; Wedel H
    Lancet; 2003 Sep; 362(9389):1076-7; author reply 1077-8. PubMed ID: 14522542
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: a prospective analysis of admission, discharge, and 6-month follow-up medication costs.
    Cunningham JL; Rome JD; Kerkvliet JL; Townsend CO
    Pain Med; 2009; 10(5):787-96. PubMed ID: 19302437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Without short acting insulin analogs. Is therapy quality really maintained? (interview by Dirk Einecke)].
    Lüddeke HJ
    MMW Fortschr Med; 2006 Sep; 148(37):9. PubMed ID: 17036893
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta-blocker therapy for heart failure: the evidence is in, now the work begins.
    Califf RM; O'Connor CM
    JAMA; 2000 Mar; 283(10):1335-7. PubMed ID: 10714735
    [No Abstract]   [Full Text] [Related]  

  • 39. Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with heart failure.
    Aquilante CL; Terra SG; Schofield RS; Pauly DF; Hatton PS; Binkley PF; Johnson JA
    J Card Fail; 2006 Apr; 12(3):171-6. PubMed ID: 16624680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metoprolol succinate therapy associated with erythema multiforme.
    Hong JA; Bisognano JD
    Cardiol J; 2009; 16(1):82-3. PubMed ID: 19130421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.